These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 19330170)

  • 1. The value of drug repositioning in the current pharmaceutical market.
    Tobinick EL
    Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in risks associated with new drug development: success rates for investigational drugs.
    DiMasi JA; Feldman L; Seckler A; Wilson A
    Clin Pharmacol Ther; 2010 Mar; 87(3):272-7. PubMed ID: 20130567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biomarkers: "Found in translation"].
    Lockhart BP; Walther B
    Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The year's new drugs and biologics--2007.
    Graul AI; Prous JR; Barrionuevo M; Bozzo J; Castaner R; Cruces E; Revel L; Rosa E; Serradell N; Sorbera LA
    Drug News Perspect; 2008; 21(1):7-35. PubMed ID: 18301807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The year's new drugs & biologics - 2008.
    Graul AI; Revel L; Barrionuevo M; Cruces E; Rosa E; Verges C; Lupone B; Diaz N; Castaner R
    Drug News Perspect; 2009; 22(1):7-29. PubMed ID: 19209296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keynote review: Is declining innovation in the pharmaceutical industry a myth?
    Schmid EF; Smith DA
    Drug Discov Today; 2005 Aug; 10(15):1031-9. PubMed ID: 16055019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From biomarker strategies to biomarker activities and back.
    van Gool AJ; Henry B; Sprengers ED
    Drug Discov Today; 2010 Feb; 15(3-4):121-6. PubMed ID: 19931413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing and adverse event prediction using high-throughput literature analysis.
    Deftereos SN; Andronis C; Friedla EJ; Persidis A; Persidis A
    Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):323-34. PubMed ID: 21416632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development: from concept to marketing!
    Tamimi NA; Ellis P
    Nephron Clin Pract; 2009; 113(3):c125-31. PubMed ID: 19729922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for bringing drug delivery tools into discovery.
    Kwong E; Higgins J; Templeton AC
    Int J Pharm; 2011 Jun; 412(1-2):1-7. PubMed ID: 21421040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic therapeutic peptides: science and market.
    Vlieghe P; Lisowski V; Martinez J; Khrestchatisky M
    Drug Discov Today; 2010 Jan; 15(1-2):40-56. PubMed ID: 19879957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
    Correia ML; Haynes WG
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based drug development: a rational approach to efficiently accelerate drug development.
    Milligan PA; Brown MJ; Marchant B; Martin SW; van der Graaf PH; Benson N; Nucci G; Nichols DJ; Boyd RA; Mandema JW; Krishnaswami S; Zwillich S; Gruben D; Anziano RJ; Stock TC; Lalonde RL
    Clin Pharmacol Ther; 2013 Jun; 93(6):502-14. PubMed ID: 23588322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial drug discovery: is it all downhill from here?
    Projan SJ; Shlaes DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The year's new drugs and biologics--2006.
    Graul AI; Sorbera LA; Bozzo J; Serradell N; Revel L; Prous JR
    Drug News Perspect; 2007; 20(1):17-44. PubMed ID: 17332898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mining small-molecule screens to repurpose drugs.
    Swamidass SJ
    Brief Bioinform; 2011 Jul; 12(4):327-35. PubMed ID: 21715466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The discovery process in the pharmaceutical industry].
    Scatton B
    J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of developing imaging agents for routine clinical use.
    Nunn AD
    Invest Radiol; 2006 Mar; 41(3):206-12. PubMed ID: 16481902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.